^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

TNFRSF8 positive

i
Other names: TNFRSF8, TNF Receptor Superfamily Member 8, Tumor Necrosis Factor Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30, Tumor Necrosis Factor Receptor Superfamily, Member 8, Cytokine Receptor CD30, CD30 Antigen, TNFRSF8, Ki-1
Entrez ID:
Related biomarkers:
1year
Clinical • Combination therapy
|
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
|
Rituxan (rituximab) • doxorubicin hydrochloride • cyclophosphamide • Adcetris (brentuximab vedotin)
almost2years
Clinical
|
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
|
Adcetris (brentuximab vedotin)
almost3years
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
3years
Clinical
|
TNFRSF8 (TNF Receptor Superfamily Member 8)
|
TNFRSF8 positive
|
Adcetris (brentuximab vedotin)